Truliant Porous Knee System Launches Reports Exactech

Truliant Porous Knee System Full Launch

Exactech, a developer and producer of innovative implants, instrumentation and smart technologies for joint replacement surgery, today announced the expansion of its Truliant® Total Knee System with a new porous-coated implant option.

Full launch of the Truliant Porous Knee System is welcome news for surgeons who are interested in a non-cemented approach. It enhances the award-winning knee system and is designed for strength and stability for patients, and efficiency for surgeons and staff in the operating room.

“Exactech’s Truliant Porous Knee system embodies state-of-the-art technology, manufacturing and instrumentation allowing surgeons to confidently address our ever-changing patient populations,” said James B. Duke, MD, of the Orthopaedic Institute in Ocala, Fla. “I believe surgeons looking to maximize longevity, performance and durability in their implants will want to utilize Exactech’s Truliant Porous Knee technology to best handle surgical challenges and patient expectations.”

The Truliant Porous Knee enhances the company’s advanced material science platform with a solution that is designed to mimic the trabecular nature of cancellous bone with optimal pore size and porosity. The porous structures integrated into the implant design are designed to facilitate a durable bonding surface to allow for immediate and long-term biological fixation. Peripheral pegs allow for stable initial fixation while the channeled keel is designed with flutes to increase bony-implant engagement for increased stability and resistance to micromotion.

The Truliant Porous Knee seamlessly integrates with the system’s ergonomically designed mechanical instrumentation and the ExactechGPS® TKA Pro application for a guided, personalized experience. The Truliant Total Knee System includes cruciate-retaining and posterior-stabilized implants, as well as constrained insert options, and integrates with a fully comprehensive revision system that offers metaphyseal cones, stems, tibial augments and offsets.

SourceExactech

Hot this week

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.